Early research (Phase 1)Looking for participantsNCT06613100What this trial is testingEvaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerWho this might be right forProstate Cancer Amgen 40
Not applicableUnknownNCT00392535What this trial is testingIntensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate CancerWho this might be right forProstate Cancer Institute of Cancer Research, United Kingdom 3,216
Not applicableActive Not RecruitingNCT06434649What this trial is testingPosterior Extra-fascial RARP in Intermediate or High Risk Prostate CancerWho this might be right forSurgical Procedure, UnspecifiedProstate Cancer Ning Xu 118
Early research (Phase 1)Ended earlyNCT01642732What this trial is testingStudy of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate CancerWho this might be right forProstate Cancer University of Michigan Rogel Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT03279250What this trial is testingApalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate CancerWho this might be right forProstate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8+2 more M.D. Anderson Cancer Center 86
Large-scale testing (Phase 3)Active Not RecruitingNCT05050084What this trial is testingTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialWho this might be right forProstate Adenocarcinoma NRG Oncology 2,050
Not applicableStudy completedNCT03368547What this trial is testing68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before SurgeryWho this might be right forProstate AdenocarcinomaStage IIB Prostate Cancer AJCC v7Stage III Prostate Cancer AJCC v7+1 more Jonsson Comprehensive Cancer Center 400
Not applicableNot Yet RecruitingNCT07709338What this trial is testingTargeted Biopsy, Rapid Pathology, and Immediate Surgery in USTC High-Risk Prostate Cancer: A Prospective Multicenter StudyWho this might be right forProstate Cancer Anhui Provincial Hospital 150
Not applicableLooking for participantsNCT06270043What this trial is testingFocal Therapy for Localized Prostate CancerWho this might be right forProstate Cancer University of California, San Diego 500
Early research (Phase 1)Study completedNCT02064608What this trial is testingInvestigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate CancerWho this might be right forProstate Cancer Cambridge University Hospitals NHS Foundation Trust 23
Testing effectiveness (Phase 2)Study completedNCT02789878What this trial is testingNeoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate CancerWho this might be right forProstate Cancer Instituto do Cancer do Estado de São Paulo 64
Not applicableLooking for participantsNCT06521710What this trial is testingNerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical ProstatectomyWho this might be right forProstate CancerErectile Dysfunction Sir Mortimer B. Davis - Jewish General Hospital 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT07766122What this trial is testingAnalysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFUWho this might be right forProstate Cancer - RecurrentProstate Cancer (Diagnosis) University Hospital, Toulouse 30
Testing effectiveness (Phase 2)UnknownNCT02283346What this trial is testingSingle Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II TrialWho this might be right forProstatic Neoplasms AC Camargo Cancer Center 60
Not applicableLooking for participantsNCT07422597What this trial is testingProstate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate CancerWho this might be right forProstate Cancer Norwegian University of Science and Technology 1,016
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282197What this trial is testingDarolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019Who this might be right forProstate Cancer Peking University First Hospital 40
Early research (Phase 1)Ended earlyNCT03066154What this trial is testingOral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate CancerWho this might be right forProstatic Neoplasms The Netherlands Cancer Institute 24
Testing effectiveness (Phase 2)Ended earlyNCT01704027What this trial is testingSafety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate CancerWho this might be right forProstate Cancer Centre Georges Francois Leclerc 28
Not applicableStudy completedNCT01812902What this trial is testingProspective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical ProstatectomyWho this might be right forProstate Cancer University of Sao Paulo 260
Not applicableStudy completedNCT02064946What this trial is testingHigh-dose Vitamin D Supplementation for ADT-induced Side EffectsWho this might be right forProstatic NeoplasmsBone Mineral Density Quantitative Trait Locus 3 University of Rochester 108